-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, researchers have verified the clinical utility of plasma neurofilament light chain (NfL) in diagnosing Symptomatic Alzheimer’s disease with Down’s syndrome, assessing its prognostic value, and determining the longitudinal changes in adults with Down’s syndrome
Multicenter cohort study
- Between August 2, 2010 and July 16, 2019, a total of 608 samples from 236 Down’s syndrome patients were analyzed: 165 (70%) were asymptomatic, and 32 (14%) had prodrome.
The plasma NfL concentration has excellent diagnostic and prognostic performance for symptomatic Alzheimer's disease in Down syndrome
Leave a message here